Back to Research Hub
Nektar Therapeutics
NKTR
$56.23-0.39 (-0.69%)
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally.
StreetsValue research for Nektar Therapeutics (NKTR)
Members get the full report for Nektar Therapeutics: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.